Search
LV305
go.drugbank.com/drugs/DB17288InvestigationalLV305 is an active component of CMB305 along with [G305].[L47346]
Olpasiran
go.drugbank.com/drugs/DB19001InvestigationalOlpasiran is under investigation in clinical trial NCT05581303 (Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (Ocean(a)) - Outcomes Trial).
Streptodornase
go.drugbank.com/drugs/DB19273InvestigationalStreptodornase is under investigation in clinical trial NCT04252963 (Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(streptokinase • Streptodornase)).
Procizumab
go.drugbank.com/drugs/DB23041InvestigationalProcizumab is under investigation in clinical trial NCT06331884 (Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)).
NBQ72S
go.drugbank.com/drugs/DB26052InvestigationalNBQ72S is under investigation in clinical trial NCT06810804 (A Phase IIa Study to Evaluate NBQ72S).
Gemcabene
go.drugbank.com/drugs/DB05123InvestigationalGemcabene is a new drug that lowers low-density lipoprotein cholesterol (LDL-C), decreases triglycerides, and raises high-density lipoprotein cholesterol (HDL-C).
OP-145
go.drugbank.com/drugs/DB05672ExperimentalOP-145 is a synthetic antimicrobial peptide developed from human cathelicidin LL-37.
EGEN-001
go.drugbank.com/drugs/DB05953InvestigationalEGEN-001 is a novel non-viral vector consisting of a plasmid DNA encoding the human gene for interleukin 12 (IL-12) and a biocompatible, biodegradable delivery polymer with potential antineoplastic activity.